Canadian Diabetes Association's clinical practice guidelines for diabetes and private and commercial driving

Canadian Journal of Diabetes

Volumn 27, Issue 2, 2003, Pages 128-140

  Begg, Iain S ^a,e   Yale, Jean François ^b   Houlden, Robyn L ^c   Rowe, Richard C ^d   McSherry, James ^f  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c QUEEN S UNIVERSITY   (Canada)

^d QUEEN ELIZABETH II HEALTH SCIENCES CENTRE   (Canada)

^e Laurel Medical Centre   (Canada)

^f NONE

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN;

CANADA; COGNITIVE DEFECT; DIABETES MELLITUS; DRIVING ABILITY; HUMAN; HYPOGLYCEMIA; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; MEDICAL SOCIETY; MEDLINE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRACTICE GUIDELINE; PREDICTION; REVIEW; RISK ASSESSMENT; TRAFFIC ACCIDENT;

EID: 0042470440     PISSN: 14992671     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (51)

1. Canadian Diabetes Association. Position statement: driving and licensing. Available at: http://www.diabetes.ca/Section_Advocacy/advDriving.asp. Accessed April 16, 2003.
2. Yale J-F, Dawson K, Dean H, et al. Canadian Diabetes Association: Clinical & Scientific Section position statement on diabetes and commercial driving. Can Diabetes. 1991;4(2):1-4.
3. Yale J-F. The 1991 position statement on diabetes and commercial driving: is it relevant in 1994? Can J Diabetes Care. 1994;18(2):13.
4. Meltzer S, Leiter L, Daneman D, et al. 1998 clinical practice guidelines for the management of diabetes in Canada. CMAJ. 1998;159(suppl 8):S1-S29.
5. Yale J-F, Begg I, Gerstein H, et al. 2001 Canadian Diabetes Association clinical practice guidelines for the prevention and management of hypoglycemia in diabetes. Can J Diabetes. 2002;26:22-35.
6. Songer TJ, Lave LB, LaPorte RE. The risks of licensing persons with diabetes to drive trucks. Risk Anal. 1993;13:319-326.
7. Adverse events and their association with treatment regimens in the Diabetes Control and Complications Trial. Diabetes Care. 1995;18:1415-1427.
8. Mühlhauser I, Overmann H, Bender R, et al. Risk factors of severe hypoglycaemia in adult patients with type I diabetes - a prospective population based study. Diabetologia. 1998;41:1274-1282.
9. Abraira C, Colwell JA, Nuttall FQ, et al. Veterans Affairs Cooperative Study on glycemic control and complications in type II diabetes (VA CSDM). Results of the feasibility trial, Veterans Affairs Cooperative Study in Type II Diabetes. Diabetes Care. 1995;18:1113-1123.
10. Saudek CD, Duckworth WC, Giobbie-Hurder A, et al. Implantable insulin pump vs multiple-dose insulin for non-insulin-dependent diabetes mellitus: a randomized clinical trial. Department of Veterans Affairs Implantable Insulin Pump Study Group. JAMA. 1996;276:1322-1327.
11. Shichiri M, Kishikawa H, Ohkubo Y, Wake N. Long-term results of the Kumamoto study on optimal diabetes control in type 2 diabetic patients. Diabetes Care. 2000;23(suppl 2):B21-B29.
12. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837-853.
13. van Staa T, Abenhaim L, Monette J. Rates of hypoglycemia in users of sulfonylureas. J Clin Epidemiol. 1997;50:735-741.
14. The DCCT Research Group. Epidemiology of severe hypoglycemia in the Diabetes Control and Complications Trial. Am J Med. 1991;90:450-459.
15. Kerr D, Macdonald IA, Tattersall RB. Patients with type 1 diabetes adapt acutely to sustained mild hypoglycaemia. Diabet Med. 1991;8:123-128.
16. Blackman JD, Towle VL, Sturis J, et al. Hypoglycemia thresholds for cognitive dysfunction in IDDM. Diabetes. 1992;41:392-399.
17. Lindgren M, Eckert B, Stenberg G, Agardh CD. Restitution of neurophysiological functions, performance, and subjective symptoms after moderate insulin-induced hypoglycaemia in non-diabetic men. Diabet Med. 1996;13:218-225.
18. Mitrakou A, Ryan C, Veneman T, et al. Hierarchy of glycemic thresholds for counterregulatory hormone secretion, symptoms, and cerebral dysfunction. Am J Physiol. 1991;260:E67-E74.
19. Cryer PE. Banting lecture. Hypoglycemia: the limiting factor in the management of IDDM. Diabetes. 1994;43:1378-1389.
20. Clanston I, Amiel SA. Hypoglycaemia update. In: Marshall SM, Home PD, Rizza RA, eds. The Diabetes Annual 10. Amsterdam: Elsevier Science B V; 1996:169-191.
21. Fanelli CG, Paramore DS, Hershey T, et al. Impact of nocturnal hypoglycemia on hypoglycemic cognitive dysfunction in type 1 diabetes. Diabetes. 1998;47:1920-1927.
22. Songer TJ. Motor vehicle accidents in persons with IDDM: is intensive treatment dangerous for IDDM drivers [abstract]? Diabetes. 1996;45(suppl 2):114A. Abstract 418.
23. Korzon-Burakowska A, Hopkins D, Matyka K, et al. Effects of glycemic control on protective responses against hypoglycemia in type 2 diabetes. Diabetes Care. 1998;21:283-290.
24. Matyka K, Evans M, Lomas J, et al. Altered hierarchy of protective responses against severe hypoglycemia in normal aging in healthy men. Diabetes Care. 1997;20:135-141.
25. Brierley EJ, Broughton DL, James OF, Alberti KG. Reduced awareness of hypoglycaemia in the elderly despite an intact counter-regulatory response. QJM. 1995;88:439-445.
26. Cox DJ, Gonder-Frederick L, Clarke W. Driving decrements in type I diabetes during moderate hypoglycemia. Diabetes. 1993;42:239-243.
27. Quillian WC, Cox DJ, Gonder-Frederick LA, et al. Reliability of driving performance during moderate hypoglycemia in adults with IDDM [letter]. Diabetes Care. 1994;17:1367-1368.
28. Cox DJ, Gonder-Frederick LA, Kovatchev BP, et al. Progressive hypoglycemia's impact on driving simulation performance: occurrence, awareness, and correction. Diabetes Care. 2000;23:163-170.
29. Clarke WL, Cox DJ, Gonder-Frederick LA, Kovatchev B. Hypoglycemia and the decision to drive a motor vehicle by persons with diabetes. JAMA. 1999;282:750-754.
30. Weinger K, Kinsley BT, Levy CJ, et al. The perception of safe driving ability during hypoglycemia in patients with type 1 diabetes mellitus. Am J Med. 1999;107:246-253.
31. Eadington DW, Frier BM. Type 1 diabetes and driving experience: an eight-year cohort study. Diabet Med. 1989;6:137-141.
32. Songer TJ, LaPorte RE, Dorman JS, et al. Motor vehicle accidents and IDDM. Diabetes Care. 1988;11:701-707.
33. Chantelau E, Dannbeck S, Kimmerle R, Ross D. Zur Verkehrstüchtigkeit Insulin-behandelter Diabetiker. Münchener Medizinische Wochenschrift. 1990;132:468-471.
34. Hansotia P, Broste SK. The effect of epilepsy or diabetes mellitus on the risk of automobile accidents. N Engl J Med. 1991;324:22-26.
35. Koepsell TD, Wolf ME, McCloskey L, et al. Medical conditions and motor vehicle collision injuries in older adults. J Am Geriatr Soc. 1994;42:695-700.
36. Waller JA. Chronic medical conditions and traffic safety: review of the California experience. N Engl J Med. 1965;273:1413-1420.
37. Crancer A, McMurry L. Accident and violation rates of Washington's medically restricted drivers. JAMA. 1968;205:272-276.
38. Stevens AB, Roberts M, McKane R, et al. Motor vehicle driving among diabetics taking insulin and non-diabetics. BMJ. 1989;299:591-595.
39. Davis TG, Wehling EH, Carpenter RL. Oklahoma's medically restricted drivers. A study of selected medical conditions. J Okla State Med Assoc. 1973;66:322-327.
40. Ysander L. The safety of drivers with chronic disease. Br J Ind Med. 1966;23:28-36.
41. Mathiesen B, Borch-Johnsen K. Diabetes and accident insurance. A 3-year follow-up of 7,599 insured diabetic individuals. Diabetes Care. 1997;20:1781-1784.
42. Ysander L. Sick and handicapped drivers. A study on the risks of sudden illness at the wheel and on the frequency of road accidents and traffic offences in chronically sick, disabled, and elderly drivers. Acta Chir Scand Suppl. 1969;409:1-82.
43. de Klerk NH, Armstrong BK. Admission to hospital for road trauma in patients with diabetes mellitus. J Epidemiol Community Health. 1983;37:232-237.
44. Gresset J, Meyer F. Risk of automobile accidents among elderly drivers with impairments or chronic diseases. Can J Public Health. 1994;85:282-285.
45. Lave LB, Songer TJ, LaPorte RE. Should persons with diabetes be licensed to drive trucks? Risk management. Risk Anal. 1993;13:327-334.
46. Dionne G, Desjardins D, Laberge-Nadeau C, Maag U. Medical conditions, risk exposure, and truck drivers' accidents: an analysis with count data regression models. Accid Anal Prev. 1995;27:295-305.
47. Laberge-Nadeau C, Dionne G, Maag U, et al. Medical conditions and the severity of commercial motor vehicle driver's road accidents. Accid Anal Prev. 1996;28:43-51.
48. Laberge-Nadeau C, Dionne G, Ékoé J-M, et al. Impact of diabetes on crash risks of truck-permit holders and commercial drivers. Diabetes Care. 2000;23:612-617.
49. Coopersmith HG, Korner-Bitensky NA, Mayo NE. Determining medical fitness to drive: physicians' responsibilities in Canada. CMAJ. 1989;140:375-378.
50. Canadian Medical Association. Determining Medical Fitness to Drive: A Guide for Physicians. 6th ed. Ottawa, ON: Canadian Medical Association; 2000.
51. Ferris LE, Barkun H, Carlisle J, et al. Defining the physician's duty to warn: consensus statement of Ontario's Medical Expert Panel on Duty to Inform. CMAJ. 1998;158:1473-1479.